Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD45.1 antibody (APC)

This Mouse Monoclonal antibody specifically detects CD45.1 in FACS. It exhibits reactivity toward Mouse.
Catalog No. ABIN6728325

Quick Overview for CD45.1 antibody (APC) (ABIN6728325)

Target

CD45.1 (CD45 (CD45.1 Allogen))

Reactivity

Mouse

Host

  • 42
Mouse

Clonality

  • 42
Monoclonal

Conjugate

  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
This CD45.1 antibody is conjugated to APC

Application

  • 42
  • 11
  • 9
  • 8
  • 3
  • 2
  • 1
Flow Cytometry (FACS)

Clone

A20
  • Isotype

    IgG2a, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Matching Isotype Control: APC Mouse IgG2a, κ Isotype Control (ABIN7469789)

    Restrictions

    For Research Use only
  • Concentration

    0.2 mg/mL

    Buffer

    PBS with 0.05 % Proclin300, 1 % BSA

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 2~8°C and protected from prolonged exposure to light. Do not freeze.
  • Target

    CD45.1 (CD45 (CD45.1 Allogen))

    Alternative Name

    CD45.1

    Background

    Ly-5,L-CA,T200,CD45,Ptprc,CD45.1 is an alloantigen of CD45, expressed by Ly5.1 bearing mouse strains (e.g., RIII, SJL/J, STS/A, DA). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in mice that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell types. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

    Gene ID

    19264

    UniProt

    P06800
You are here:
Chat with us!